Translational Potential of Therapeutics Targeting Regulatory Myeloid Cells in Tuberculosis
Despite recent advances in tuberculosis (TB) drug development and availability, successful antibiotic treatment is challenged by the parallel development of antimicrobial resistance. As a result, new approaches toward improving TB treatment have been proposed in an attempt to reduce the high TB morb...
Main Authors: | Nelita du Plessis, Leigh A. Kotze, Vinzeigh Leukes, Gerhard Walzl |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-09-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcimb.2018.00332/full |
Similar Items
-
Myeloid-Derived Suppressor Cells as Target of Phosphodiesterase-5 Inhibitors in Host-Directed Therapeutics for Tuberculosis
by: Vinzeigh Leukes, et al.
Published: (2020-03-01) -
Sildenafil, a Type-5 Phosphodiesterase Inhibitor, Fails to Reverse Myeloid-Derived Suppressor Cell-Mediated T Cell Suppression in Cells Isolated From Tuberculosis Patients
by: Vinzeigh N. Leukes, et al.
Published: (2022-07-01) -
The Emerging Role of Myeloid-Derived Suppressor Cells in Tuberculosis
by: Tandeka Magcwebeba, et al.
Published: (2019-04-01) -
Corrigendum: The Emerging Role of Myeloid-Derived Suppressor Cells in Tuberculosis
by: Tandeka Magcwebeba, et al.
Published: (2019-07-01) -
Suppressive myeloid cells in SARS-CoV-2 and Mycobacterium tuberculosis co-infection
by: Jane Alexandra Shaw, et al.
Published: (2023-07-01)